We are live on ! Find out more
JAMONY

Jacob Asset Management of New York Portfolio holdings

AUM $70.9M
1-Year Est. Return 14.28%
This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+14.28%
3 Year Est. Return
+22.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$92.1M
AUM Growth
-$6.88M
Cap. Flow
-$3.27M
Cap. Flow %
-3.55%
Top 10 Hldgs %
40.07%
Holding
71
New
1
Increased
30
Reduced
23
Closed
4

Top Buys

Rank Stock Value
1
OPRX icon
OptimizeRx
OPRX
+$1.2M
2
ATOM icon
Atomera
ATOM
+$887K
3
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$864K
4
POSH
Poshmark, Inc. Class A Common Stock
POSH
+$689K
5
TWLO icon
Twilio
TWLO
+$567K

Top Sells

Rank Stock Value
1
PI icon
Impinj
PI
+$2.64M
2
AERI
Aerie Pharmaceuticals
AERI
+$1.58M
3
SI
Silvergate Capital Corporation
SI
+$852K
4
CFRX
ContraFect Corporation
CFRX
+$761K
5
INSE icon
Inspired Entertainment
INSE
+$753K

Sector Composition

Rank Sector Weight
1 Technology 43.34%
2 Healthcare 24.49%
3 Consumer Discretionary 10.37%
4 Industrials 7.29%
5 Financials 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OMER icon
51
Omeros
OMER
$992M
$277K 0.3%
87,928
-4,000
-4% -$18.5K
DMTK
52
DELISTED
DermTech, Inc. Common Stock
DMTK
$270K 0.29%
68,303
-3,439
-5% -$21.1K
KRYS icon
53
Krystal Biotech
KRYS
$9.85B
$262K 0.28%
3,762
-965
-20% -$69.7K
AEO icon
54
American Eagle Outfitters
AEO
$2.72B
$240K 0.26%
24,669
+3,000
+14% +$34.9K
TWST icon
55
Twist Bioscience
TWST
$7.85B
$228K 0.25%
6,482
-317
-5% -$13.5K
SDGR icon
56
Schrodinger
SDGR
$1.39B
$216K 0.23%
8,651
-1,028
-11% -$30.2K
IZEA icon
57
IZEA Worldwide
IZEA
$53.8M
$210K 0.23%
73,625
+5,000
+7% +$17.5K
BEAM icon
58
Beam Therapeutics
BEAM
$2.76B
$197K 0.21%
4,137
+333
+9% +$19K
NBSE
59
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$186K 0.2%
23,526
– –
APLS
60
DELISTED
Apellis Pharmaceuticals
APLS
$182K 0.2%
2,659
+1,005
+61% +$59.5K
CRSP icon
61
CRISPR Therapeutics
CRSP
$5.22B
$173K 0.19%
2,642
-256
-9% -$18.6K
LEJU
62
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$169K 0.18%
94,545
– –
QUMU
63
DELISTED
Qumu Corp.
QUMU
$163K 0.18%
267,030
– –
ICAD
64
DELISTED
iCAD Inc
ICAD
$142K 0.15%
67,819
-10,000
-13% -$32.7K
BJRI icon
65
BJ's Restaurants
BJRI
$1.48B
$119K 0.13%
5,000
-1,000
-17% -$24.6K
IMV
66
DELISTED
IMV Inc. Common Shares
IMV
$111K 0.12%
21,150
– –
ATHX
67
DELISTED
Athersys, Inc. Common Stock
ATHX
$22K 0.02%
12,000
-6,000
-33% -$26.2K
GOOG icon
68
Alphabet (Google) Class C
GOOG
$4.19T
– –
-2,220
Closed -$243K
AERI
69
DELISTED
Aerie Pharmaceuticals
AERI
– –
-210,143
Closed -$1.58M
TWTR
70
DELISTED
Twitter, Inc.
TWTR
– –
-8,617
Closed -$322K
CFRX
71
DELISTED
ContraFect Corporation
CFRX
– –
-3,097
Closed -$761K
1 2
3

Similar funds

JCG
John C. Goff $70.7M AUM 4.99% 1-Year Est. Return
VCM
Vetamer Capital Management Menlo Park, California $72M AUM 31% 1-Year Est. Return
BS
Bessemer Securities New York $72.2M AUM 28.36% 1-Year Est. Return
TMC
Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ROC
River Oaks Capital Wayzata, Minnesota $67.9M AUM 13.58% 1-Year Est. Return
IVMX
Institutional Venture Management XIV Menlo Park, California $67.7M AUM 8.12% 1-Year Est. Return
KCM
KLK Capital Management Los Angeles, California $74.7M AUM 13.54% 1-Year Est. Return

Jacob Asset Management of New York's Q3 2022 Portfolio in Review

As of Q3 2022, Jacob Asset Management of New York held 71 positions worth $92.1M, down 7% from $99M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Jacob Asset Management of New York withdrew a net $3.27M in Q3 2022, closing 4 positions and reducing 23 holdings. Its most notable exit was Aerie Pharmaceuticals, an estimated $1.58M position sold in full.

By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 44% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Jacob Asset Management of New York opened a new position in Atomera worth $760K.

  • Jacob Asset Management of New York's largest Q3 2022 buy was Atomera: 75,000 shares worth $760K.
  • Jacob Asset Management of New York added most to OptimizeRx in Q3 2022, an estimated $1.2M increase.
  • Jacob Asset Management of New York's biggest Q3 2022 reduction was Impinj, cutting an estimated $2.64M.
  • Jacob Asset Management of New York fully exited Aerie Pharmaceuticals in Q3 2022, selling an estimated $1.58M.
  • Jacob Asset Management of New York's ten largest holdings make up 40% of its $92.1M portfolio in Q3 2022.
  • Jacob Asset Management of New York opened 1 new position and closed 4 in Q3 2022.
  • Jacob Asset Management of New York's portfolio value fell 7% quarter-over-quarter to $92.1M.

Based on Jacob Asset Management of New York's 13F filing for Q3 2022, filed 10 Nov 2022.